Skip to content

MEDICAL TECHNOLOGIES & SYSTEMS: what changed

BE 0660.821.507NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€1,433
2024 · €7,773-€6,339
Equity
€29,846
2024 · €28,412+€1,433
Cash
-
2024 · €47,733-€47,733
Balance sheet total
€68,801
2024 · €106,889-€38,087

Largest movements

2024 to 2025
Assets
  • Cash -€47,733

    no longer reported in 2025 (was €47,733)

    mainly Trade debts (-€40,906) and Receivables after one year (-€23,800)

  • Receivables after one year +€23,800

    up €23,800 (+218%), from €10,900 to €34,700

  • Receivables within one year -€17,985

    down €17,985 (-57.3%), from €31,368 to €13,383

    of which Trade receivables: -€17,685

  • Stocks and contracts +€2,940

    up €2,940 (+23.5%), from €12,495 to €15,435

  • Deferred charges and accrued income +€1,884

    new in 2025: €1,884

Equity and liabilities
  • Trade debts -€40,906

    down €40,906 (-88.5%), from €46,228 to €5,322

  • Short-term financial debts +€31,330

    new in 2025: €31,330

  • Tax, wage and social debts -€19,935

    down €19,935 (-89.6%), from €22,238 to €2,304

  • Reserves +€9,000

    up €9,000 (+462%), from €1,950 to €10,950

    of which Distributable reserves: +€9,000

  • Profit (loss) carried forward -€7,567

    down €7,567 (-96.2%), from €7,862 to €296

Income statement
  • Write-downs +€20,055

    new in 2025: €20,055

  • Financial charges -€7,348

    down €7,348 (-73.9%), from €9,945 to €2,596

  • Gross operating margin +€3,336

    up €3,336 (+13.2%), from €25,324 to €28,660

  • Taxes -€3,247

    down €3,247 (-67.1%), from €4,838 to €1,591

  • Other operating charges +€895

    up €895 (+50.3%), from €1,780 to €2,675

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €7,773
Gross operating margin +€3,336
Write-downs -€20,055
Other operating charges -€895
Financial income +€679
Financial charges +€7,348
Taxes +€3,247
Result 2025 €1,433
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€79,063
Investment €0
Financing +€31,330
Cash 2024 €47,733
Net result for the year +€1,433
Depreciation +€994
Receivables after one year -€23,800
Stocks and contracts -€2,940
Receivables within one year +€17,985
Deferred charges and accrued income -€1,884
Trade debts -€40,906
Tax, wage and social debts -€19,935
Advances received -€4,110
Other debts -€5,900
Short-term financial debts +€31,330
Cash 2025 €0
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €106,889 €68,801 -€38,087 -35.6%
Fixed assets 21/28 €4,393 €3,399 -€994 -22.6%
Tangible fixed assets 22/27 €4,393 €3,399 -€994 -22.6%
Furniture and vehicles 24 €188 €35 -€153 -81.3%
Other tangible fixed assets 26 €4,205 €3,364 -€841 -20.0%
Current assets 29/58 €102,496 €65,402 -€37,094 -36.2%
Amounts receivable after more than one year 29 €10,900 €34,700 +€23,800 +218%
Other amounts receivable 291 €10,900 €34,700 +€23,800 +218%
Stocks and contracts in progress 3 €12,495 €15,435 +€2,940 +23.5%
Stocks 30/36 €12,495 €15,435 +€2,940 +23.5%
Amounts receivable within one year 40/41 €31,368 €13,383 -€17,985 -57.3%
Trade receivables 40 €30,962 €13,277 -€17,685 -57.1%
Other amounts receivable 41 €406 €106 -€301 -74.0%
Cash at bank and in hand 54/58 €47,733 - -€47,733
Deferred charges and accrued income 490/1 - €1,884 +€1,884
Total equity and liabilities 10/49 €106,889 €68,801 -€38,087 -35.6%
Equity 10/15 €28,412 €29,846 +€1,433 +5.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,950 €10,950 +€9,000 +462%
Non-distributable reserves 130/1 €950 €950 = 0.0%
Reserves not available under the articles 1311 €950 €950 = 0.0%
Distributable reserves 133 €1,000 €10,000 +€9,000 +900%
Profit (loss) carried forward 14 €7,862 €296 -€7,567 -96.2%
Amounts payable 17/49 €78,476 €38,956 -€39,521 -50.4%
Amounts payable within one year 42/48 €78,476 €38,956 -€39,521 -50.4%
Financial debts 43 - €31,330 +€31,330
Credit institutions 430/8 - €31,330 +€31,330
Trade debts 44 €46,228 €5,322 -€40,906 -88.5%
Suppliers 440/4 €46,228 €5,322 -€40,906 -88.5%
Advances received on contracts in progress 46 €4,110 - -€4,110
Taxes, remuneration and social security 45 €22,238 €2,304 -€19,935 -89.6%
Taxes 450/3 €22,238 €2,304 -€19,935 -89.6%
Other amounts payable 47/48 €5,900 - -€5,900
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €994 €994 = 0.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €20,055 +€20,055
Other operating charges 640/8 €1,780 €2,675 +€895 +50.3%
Gross operating margin 9900 €25,324 €28,660 +€3,336 +13.2%
Operating profit (loss) 9901 €22,550 €4,936 -€17,614 -78.1%
Financial income 75/76B €5 €684 +€679 +13,237%
Recurring financial income 75 €5 €684 +€679 +13,237%
Financial charges 65/66B €9,945 €2,596 -€7,348 -73.9%
Recurring financial charges 65 €9,945 €2,596 -€7,348 -73.9%
Profit (loss) for the period before taxes 9903 €12,611 €3,024 -€9,586 -76.0%
Income taxes 67/77 €4,838 €1,591 -€3,247 -67.1%
Profit (loss) for the period 9904 €7,773 €1,433 -€6,339 -81.6%
Profit (loss) for the period to be appropriated 9905 €7,773 €1,433 -€6,339 -81.6%

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€32,016 to €38,853

Midpoint €34,864 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €29,846
Capitalised earnings €34,186 to €47,860
Indication €32,016 to €38,853

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€29,846
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€29,846

Capitalised earnings

net result for the year (9904)
2025
€1,433
2024
€7,773
2023
€5,153
2022
€3,320
2021
€18,861
Average result
€4,786
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€34,186 / €39,883 / €47,860

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.